191.038 articles found

Cell therapy for Parkinson's disease is coming of age: current challenges and future prospects with a focus on immunomodulation.

Wenker SD, Pitossi FJ.

Gene Ther · 2019-04-16

DOI: 10.1038/s41434-019-0077-4PMID: 30992523

Association Between Subglottic Pressure and Pulmonary Function in Individuals With Parkinson's Disease.

Castillo A, Castillo J, Reyes A.

J Voice · 2019-04-16

DOI: 10.1016/j.jvoice.2019.03.001PMID: 31000398

SAT-473 Acromegaly and Drug-Induced Parkinsonism Were Controlled by Lanreotide

Iwabuchi M.

Journal of the Endocrine Society · 2019-04-15

7.0T ultrahigh-field MRI directly visualized the pedunculopontine nucleus in Parkinson's disease patients.

Wang JW, Cong F, Zhuo Y, Chen L, Wang B, Zhang YQ.

Clinics (Sao Paulo) · 2019-04-15

DOI: 10.6061/clinics/2019/e573PMID: 30994703

Emotional Processing Impairments in Apathetic Patients with Parkinson's Disease: An ERP Study in Early Time Windows.

Wei W, Ruan J, Duan X, Luo H.

Parkinsons Dis · 2019-04-15

DOI: 10.1155/2019/1309245PMID: 31143435

The Association between DRD3 Ser9Gly Polymorphism and Depression Severity in Parkinson's Disease.

Zhi Y, Yuan Y, Si Q, Wang M, Shen Y, Wang L, Zhang H, Zhang K.

Parkinsons Dis · 2019-04-15

DOI: 10.1155/2019/1642087PMID: 31143436

Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model.

Flores-Cuadrado A, Saiz-Sanchez D, Mohedano-Moriano A, Martinez-Marcos A, Ubeda-Bañon I.

Acta Neuropathol Commun · 2019-04-15

DOI: 10.1186/s40478-019-0713-7PMID: 30987677

Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism.

Sjöström H, Surova Y, Nilsson M, Granberg T, Westman E, van Westen D, Svenningsson P, Hansson O.

Sci Rep · 2019-04-15

DOI: 10.1038/s41598-019-42565-4PMID: 30988382

Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson's Disease.

Bajracharya R, Youngson NA, Ballard JWO.

Int J Mol Sci · 2019-04-15

DOI: 10.3390/ijms20081850PMID: 30991634

Prominent Oromandibular Dystonia as Levodopa-induced Dyskinesia in Idiopathic Parkinson's Disease.

Tee TY, Khoo CS, Norlinah MI.

Mov Disord Clin Pract · 2019-04-15

DOI: 10.1002/mdc3.12759PMID: 31061844

Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease.

Bhattacharjee P, Öhrfelt A, Lashley T, Blennow K, Brinkmalm A, Zetterberg H.

J Proteome Res · 2019-04-15

DOI: 10.1021/acs.jproteome.8b00982PMID: 30943367

In Vivo Phenotyping of Familial Parkinson's Disease with Human Induced Pluripotent Stem Cells: A Proof-of-Concept Study.

Zygogianni O, Antoniou N, Kalomoiri M, Kouroupi G, Taoufik E, Matsas R.

Neurochem Res · 2019-04-15

DOI: 10.1007/s11064-019-02781-wPMID: 30989481